PS218. Inhibition of CXCL4-CCL5 Chemokine Interaction Ameliorates the Development of Abdominal Aortic Aneurysm in Mice  by Iida, Yasunori et al.
m
C
v
t
b
p
l
o
p
A
Y
c
t
P
T
P
F
E
M
M
Y
l
U
S
K
s
r
o
u
r
s
g
d
c
l
m
r
s
c
(
w
l
p
m
o
c
i
d
p
JOURNAL OF VASCULAR SURGERY
June Supplement 201186S Abstracts1.05 /0.11mm and 1.24 /0.09mm in the 3-min-
ute time group (p NS between groups). Intimal hyperplasia
was modest in all rats, with no significant differences in
intimal wall areas. The intimal and medial wall area as a
percentage of overall vessel area was 35.0 /5.2% in the
30-second group and 36.8 /6.6% in the 3-minute
group (p NS).
Conclusions: Prolonged balloon inflation time failed
to produce significant changes in intimal disruption after
24 hours. At 30 days, there was no difference in the amount
of intimal hyperplasia, medial wall thickening, or lumen
diameter compared to standard inflation times. These re-
sults do not support changing current balloon angioplasty
practices.
Author Disclosures: D. Boone: Nothing to disclose; G.
Jour: Nothing to disclose; J. C. Lantis: Nothing to dis-
close; G. S. Schwartz: Nothing to disclose.
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PS218.
Inhibition of CXCL4-CCL5 Chemokine Interaction
Ameliorates the Development of Abdominal Aortic
Aneurysm in Mice
Yasunori Iida1, Baohui Xu1, Joshua Schultz2, Court R.
Turner2, Ronald L. Dalman1. 1Vascular Surgery, Stanford
University School of Medicine, Stanford, CA; 2Carolus
Therapeutics, Inc., La Jolla, CA
Objectives: Abdominal aortic aneurysm (AAA) is a
macrophages-driven vascular disease. Given the importance
of CXCL4-CCL5 chemokine interaction in macrophage/
monocytes migration into inflamed arteries, we evaluated
the effect of a novel synthetic peptide inhibitor to CXCL4-
CCL5 interaction on AAA progression in the porcine pan-
creatic elastase (PPE)-induced AAA mouse model.
Methods: AAA was created in 10-wk-old male
C57BL/6 mice by PPE infusion into infrarenal aorta.
These mice were injected i.v. with the synthetic peptide
inhibitor to CXCL4-CCL5 interaction (CT-2009ca, 10
(n5) or 20 (n7) mg/kg/day or the vehicle (n8)
(Carolus Therapeutics, Inc) for 3 days before PPE infusion
and 13 days thereafter. The AAA was imaged by ultra-
sonography and defined as a 50% increase in the aortic
diameter. The aortae were harvested 14 days after PPE
infusion and subjected to histopathology.
Results: AAA developed in all mice treated with the
vehicle within 7 days. In contrast, AAA developed in 3mice
and 1 mouse treated with the CT-2009ca at the dose of 10
and 20 mg /kg/day, respectively, within 14 days. The
CT-2009ca treatment dose-dependently inhibited the
PPE-induced increase in aorta diameter. Moreover, the
elastic Masson staining and the anti-smooth muscle cell
alpha actin antibody immunostaining revealed that medial
elastin fibers and smooth muscle cell layers were well pre-
served in the CT-2009ca-treated mice as compared to the
vehicle-treated mice. As expected, the CT-2009ca treat- sent significantly reduced the numbers of macrophages,
D4 T cells and neutrophils and newly formed blood
essels in the media and adventitia by immunostaining with
he mAbs against leukocyte subsets and endothelial cells.
Conclusions: In the mouse PPE model of AAA, inhi-
ition of CXCL4-CCL5 interaction by CT-2009ca sup-
ressed AAA development by reducing angiogenesis and
imitingmedial and adventitial infiltration of certain subsets
f leukocytes. Thus, CT-2009ca may be a potential thera-
eutic candidate for treating human AAA disease.
uthor Disclosures: R. L. Dalman: Nothing to disclose;
. Iida: Nothing to disclose; J. Schultz: Nothing to dis-
lose; C. R. Turner: Nothing to disclose; B. Xu: Nothing
o disclose.
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hermo-Mechanical Resistance of a Nanocomposite
olymer Exposed to Simulated in Vivo Hydrodynamic
atigue for Ten Years in Development of a Sutureless
ndovascular Stent Graft
ital Y. Desai1, Raheleh Bakhshi2, Arnold Darbyshire2,
ax Ahmed2, James Eaton-Evans3, Xiang Zhou3, Zhong
ou3, AlexanderM. Seifalian2, GeorgeHamilton1. 1Vascu-
ar Surgery, Royal Free Hampstead NHS Trust, London,
nited Kingdom; 2Division of Surgery and Interventional
cience, University College London, London, United
ingdom; 3Department of Engineering Science, Univer-
ity of Oxford, Oxford, United Kingdom
Objectives: To physiologically test thermo-mechanical
esistance of a nanocomposite polymer based on polyhedral
ligomeric silsesquioxane (POSS) and poly (carbonate-
rea) urethane (PCU) to assess its feasibility as graft mate-
ial for a sutureless aortic stent-graft by exposing it to
imulated in vivo hydrodynamic fatigue according to FDA
uidelines.
Methods: Aortic stent-grafts (n4) were tested in 37
egree Celsius distilled water using in vitro accelerated
ircumferential pulsatile model. After analysis for 400-mil-
ion cycles equivalent to 10-years in human body, the
echanical and elastic properties were determined by Fou-
ier transform infrared spectroscopy (FTIR), radial stress-
train studies, and linear elasticity tests. Dynamic scanning
alorimetry (DSC) and Thermo-mechanical analysis
TMA) were used to assess thermal resistance. Comparison
as made with zero-cycled control.
Results: All stent-grafts (n4; diameter 250.1 mm;
ength 25.30.5 cm) successfully completed accelerated
ulsatile fatigue testing at 37°C and pulse pressure 9414
m Hg over 12 months. FTIR showed increased intensity
f -NHCO- bonds (62% transmittance in tested specimen
ompared to 47% in control) but there was no difference in
ntensity of other major bonds and no significant sign of
egradation. Tensile strain of fatigue-tested polymer com-
ared favourably with zero-cycled control at 50% to 500%
tress (P0.69). When stretched up to 500% original
